Liberation Labs secures US$ 25 million loan

Agronomics Limited

01 December 2023

 

1 December 2023

Agronomics Limited

("Agronomics" or the "Company")

Liberation Labs secures US$ 25 million loan for biomanufacturing facility

Agronomics (ANIC:LSE), a leading listed company focused on the field of cellular agriculture, is pleased to announce that the United States Department of Agriculture ("USDA") has awarded Ameris Bancorp ("Ameris Bank") a US$ 25 million "Business and Industry" loan guarantee to help the continued build and the completion of Liberation Labs Holdings Inc ("Liberation Labs")'s biomanufacturing facility in Indiana, USA.

Liberation Labs is currently constructing a commercial-scale, purpose-built, precision fermentation biomanufacturing facility with a capacity of 600,000 litres and a fully dedicated downstream process. The facility is a significant step forward in addressing the critical lack of fermentation capacity facing the industry. It will allow companies to produce at the necessary commercialisation scales, the capacity required to achieve favourable unit economics. The awarded loan guarantee - made available to businesses working to spur local economic development - ensures that Liberation Labs has the necessary capital to complete the build-out of the remainder of the facility over the next year. Commercial production is expected to commence by Q1 2025.

Once completed, the facility will be purpose-built for precision fermentation products that can be delivered at an optimised cost, with increased yield production and improved efficiency for a variety of novel bio-based proteins such as precision fermentation-derived egg and dairy proteins. A 3D rendering of the sophisticated 600,000L launch facility, designed to address the acute shortage in precision fermentation capacity, can be seen here.

Agronomics has invested US$ 7.6 million into Liberation Labs since its inception, which is currently carried at £18.4 million. Subject to audit, this position accounts for approximately 10.5% of Agronomics' last published Net Asset Value (30/09/2023), including post-balance sheet date adjustments. Agronomics has an equity ownership of 37.4% on a fully diluted basis.

Mark Warner CEO and Co-founder of Liberation Labs said: -

"Award of this USDA loan guarantee is continued confirmation of the importance of adding US biomanufacturing capacity and the strength of our business plan. Our project underwent significant due diligence and risk rating, and to come out the other end with a loan guarantee is a strong reflection of the quality of our team, our vision and our ability to execute."

Jim Mellon, Executive Director of Agronomics said:-

"Liberation Labs is developing state-of-the-art purpose-built fermentation infrastructure which will transform the existing fermentation capacity and help build a future in which precision fermentation proteins reach the industrial scale needed to meet growing demand in the US and across the world. With continued progress being made and key delivery timelines on track, we look forward to the operational launch in 2025."

About Liberation Labs

Liberation Labs is commercializing precision fermentation with a global network of purpose-built manufacturing facilities that enable the next wave of biotechnology advancements to produce bio-based consumer products at scale. We combine modern technology with fit-for-purpose design to bring reliable and cost-effective solutions that meet customer demand across the world. More information is available at www.liberationlabs.com.

About Ameris Bancorp

Ameris Bancorp is a bank holding company headquartered in Atlanta, Georgia. The Company's banking subsidiary, Ameris Bank, had 164 locations in Georgia, Alabama, Florida, North Carolina and South Carolina at the end of the most recent quarter.

About Agronomics

Agronomics is a leading listed company with a focus on cellular agriculture and cultivated meat. The Company has established a portfolio of over 20 companies in this rapidly advancing sector. It seeks to invest in companies owning technologies with defensible intellectual property that offer new ways of producing food and materials with a focus on products historically derived from animals. These technologies are driving a major disruption in agriculture, offering solutions to improve sustainability, as well as addressing human health, animal welfare and environmental damage. This disruption will decouple supply chains from the environment and animals and improve food security for the world's expanding population. A full list of Agronomics' portfolio companies is available at https://agronomics.im/.

For further information please contact:

Agronomics Limited	Beaumont Cornish Limited	Canaccord Genuity Limited	Cavendish Securities Plc	Peterhouse Capital Limited	SEC Newgate
The Company	Nomad	Joint Broker	Joint Broker	Joint Broker	Public Relations
Richard Reed Denham Eke	Roland Cornish James Biddle	Andrew Potts Harry Rees Alex Aylen (Head of Equities)	Giles Balleny Michael Johnson	Lucy Williams Charles Goodfellow	Bob Huxford George Esmond Anthony Hughes Alice Cho
[phone] [e-mail]	[phone]	[phone]	[phone]	[phone]	[e-mail]

 

END